Company Filing History:
3 out of 595 
3 out of 58 
Years Active: 2018-2021
Title: The Innovative Contributions of Inventor Alison McDermott
Introduction: Alison McDermott, a prominent inventor based in Bellaire, Texas, has made significant strides in the field of synthetic antibacterial peptides. With three patents to her name, she has established herself as a noteworthy figure in the realms of medicine and antimicrobial research. Her innovative work has the potential to transform wound healing and contact lens technology.
Latest Patents: McDermott's most recent patents focus on "Esculentin 1a derivatives and uses thereof." These patents detail synthetic antibacterial peptides that have a sequence at least 80% identical to a specific sequence outlined in SEQ ID NO: 2 or its diastereomer shown in SEQ ID NO: 3. The inventions also include methods for stimulating wound healing using these synthetic peptides and developing antimicrobial coatings for contact lenses. Furthermore, a device featuring a surface coated with these synthetic antibacterial peptides is provided, showcasing her commitment to practical applications in medicine.
Career Highlights: Throughout her career, Alison McDermott has demonstrated a passion for innovation and research. Her affiliation with the University of Houston System has allowed her to contribute to both academic advancement and applied sciences. Additionally, her collaboration with "Universita Degli Studi Di Roma 'la Sapienza'" indicates her global engagement and the reach of her impactful research.
Collaborations: McDermott's work has been further enriched through collaborations with notable colleagues, including Maria Luisa Mangoni and Marialuisa Mangoni. These partnerships highlight the importance of teamwork in driving innovations and bringing research concepts to fruition.
Conclusion: Alison McDermott's innovative contributions in the field of synthetic antibacterial peptides exemplify the vital role of inventors in advancing medical technology. With her cutting-edge patents and collaborative spirit, McDermott continues to pave the way for future developments that could significantly enhance wound healing and various applications within the biomedical field.